Reportlinker Adds Global: Pharmaceuticals Industry Guide
NEW YORK, April 7, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global: Pharmaceuticals Industry Guide
http://www.reportlinker.com/p0470341/Global-Pharmaceuticals-Industry-Guide.html
Datamonitor's Global: Pharmaceuticals Industry Guide is an essential resource for top-level data and analysis covering the Global Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, Life Sciences Tools & Services, OTC Pharmaceuticals, Pharmaceuticals and Pharmaceuticals, Biotechnology & Life Sciences
Scope of the Report
* Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, Life Sciences Tools & Services, OTC Pharmaceuticals, Pharmaceuticals and Pharmaceuticals, Biotechnology & Life Sciences
* Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Includes five-year forecasts for Biotechnology, Generics, Life Sciences Tools & Services, OTC Pharmaceuticals, Pharmaceuticals and Pharmaceuticals, Biotechnology & Life Sciences
Highlights
The global biotechnology market had total revenue of $200 billion in 2009, representing a compound annual growth rate (CAGR) of 10.2% for the period spanning 2005-2009.
The global generics market had total revenue of $149.7 billion in 2009, representing a compound annual growth rate (CAGR) of 11% for the period spanning 2005-2009.
The global life sciences tools and services market generated total revenues of $18.1 billion in 2009, representing a compound annual growth rate (CAGR) of 10.5% for the period spanning 2005-2009.
The global OTC pharmaceuticals market generated total revenues of $110.7 billion in 2009, representing a compound annual growth rate (CAGR) of 3.9% for the period spanning 2005-2009.
The global pharmaceuticals market is expected to have total revenue of $693 billion in 2010, representing a compound annual growth rate (CAGR) of 4.8% for the period spanning 2006-2010.
The global pharmaceuticals, biotechnology, and life sciences industry group generated total revenues of $1,071.7 billion in 2009, representing a compound annual growth rate (CAGR) of 6.7% for the period spanning 2005-2009.
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
TABLE OF CONTENTS
GLOBAL BIOTECHNOLOGY 9
Market Overview 9
Market Value 11
Market Segmentation I 12
Market Segmentation II 13
Five Forces Analysis 14
Market Forecasts 21
GLOBAL GENERICS 23
Market Overview 23
Market Value 25
Market Volume 26
Market Segmentation II 27
Five Forces Analysis 28
Market Forecasts 36
GLOBAL LIFE SCIENCES TOOLS & SERVICES 39
Market Overview 39
Market Value 41
Market Segmentation I 42
Market Segmentation II 43
Market Share 44
Five Forces Analysis 45
Market Forecasts 53
GLOBAL OTC PHARMACEUTICALS 55
Market Overview 55
Market Value 57
Market Segmentation I 58
Market Segmentation II 59
Market Share 60
Five Forces Analysis 61
Market Distribution 69
Market Forecasts 70
GLOBAL PHARMACEUTICALS 72
Market Overview 72
Market Value 74
Market Segmentation I 75
Market Segmentation II 76
Market Share 77
Five Forces Analysis 78
Market Forecasts 88
GLOBAL PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES 90
Market Overview 90
Market Value 92
Market Segmentation I 94
Market Segmentation II 95
Market Share 96
Five Forces Analysis 98
Market Forecasts 108
APPENDIX 110
Data Research Methodology 110
About Datamonitor 111
Disclaimer 111
LIST OF TABLES
Table 1: Global biotechnology market value: $ billion, 2005–09 11
Table 2: Global biotechnology market segmentation I:% share, by value, 2009 12
Table 3: Global biotechnology Market Segmentation II: % share, by value, 2009 13
Table 4: Global biotechnology market value forecast: $ billion, 2009–14 21
Table 5: Global generics market value: $ billion, 2005–09 25
Table 6: Global generics market volume: volume penetration, 2005–09 26
Table 7: Global generics Market Segmentation II: % share, by value, 2009 27
Table 8: Global generics market value forecast: $ billion, 2009–14 36
Table 9: Global generics market volume forecast: volume penetration, 2009–14 37
Table 10: Global life sciences tools & services market value: $ billion, 2005–09 41
Table 11: Global life sciences tools & services market segmentation I:% share, by value, 2009 42
Table 12: Global life sciences tools & services Market Segmentation II: % share, by value, 2009 43
Table 13: Global life sciences tools & services market share: % share, by value, 2009 44
Table 14: Global life sciences tools & services market value forecast: $ billion, 2009–14 53
Table 15: Global OTC pharmaceuticals market value: $ million, 2005–09 57
Table 16: Global OTC pharmaceuticals market segmentation I:% share, by value, 2009 58
Table 17: Global OTC pharmaceuticals Market Segmentation II: % share, by value, 2009 59
Table 18: Global OTC pharmaceuticals market share: % share, by value, 2009 60
Table 19: Global OTC pharmaceuticals market distribution: % share, by value, 2009 69
Table 20: Global OTC pharmaceuticals market value forecast: $ million, 2009–14 70
Table 21: Global pharmaceuticals market value: $ billion, 2006–10(e) 74
Table 22: Global pharmaceuticals market segmentation I:% share, by value, 2010(e) 75
Table 23: Global pharmaceuticals Market Segmentation II: % share, by value, 2010(e) 76
Table 24: Global pharmaceuticals market share: % share, by value, 2010(e) 77
Table 25: Global pharmaceuticals market value forecast: $ billion, 2010–15 88
Table 26: Global pharmaceuticals, biotechnology & life sciences industry value: $ billion, 2005–09 92
Table 27: Global pharmaceuticals, biotechnology & life sciences industry segmentation I:% share, by value, 2009 94
Table 28: Global pharmaceuticals, biotechnology & life sciences industry segmentation II: % share, by value, 2009 95
Table 29: Global pharmaceuticals, biotechnology & life sciences industry share: % share, by value, 2009 96
Table 30: Global pharmaceuticals, biotechnology & life sciences industry value forecast: $ billion, 2009–14 108
LIST OF FIGURES
Figure 1: Global biotechnology market value: $ billion, 2005–09 11
Figure 2: Global biotechnology market segmentation I:% share, by value, 2009 12
Figure 3: Global biotechnology Market Segmentation II: % share, by value, 2009 13
Figure 4: Forces driving competition in the global biotechnology market, 2009 14
Figure 5: Drivers of buyer power in the global biotechnology market, 2009 15
Figure 6: Drivers of supplier power in the global biotechnology market, 2009 16
Figure 7: Factors influencing the likelihood of new entrants in the global biotechnology market, 2009 17
Figure 8: Factors influencing the threat of substitutes in the global biotechnology market, 2009 19
Figure 9: Drivers of degree of rivalry in the global biotechnology market, 2009 20
Figure 10: Global biotechnology market value forecast: $ billion, 2009–14 22
Figure 11: Global generics market value: $ billion, 2005–09 25
Figure 12: Global generics market volume: volume penetration, 2005–09 26
Figure 13: Global generics Market Segmentation II: % share, by value, 2009 27
Figure 14: Forces driving competition in the global generics market, 2009 28
Figure 15: Drivers of buyer power in the global generics market, 2009 30
Figure 16: Drivers of supplier power in the global generics market, 2009 31
Figure 17: Factors influencing the likelihood of new entrants in the global generics market, 2009 32
Figure 18: Factors influencing the threat of substitutes in the global generics market, 2009 34
Figure 19: Drivers of degree of rivalry in the global generics market, 2009 35
Figure 20: Global generics market value forecast: $ billion, 2009–14 36
Figure 21: Global generics market volume forecast: volume penetration, 2009–14 38
Figure 22: Global life sciences tools & services market value: $ billion, 2005–09 41
Figure 23: Global life sciences tools & services market segmentation I:% share, by value, 2009 42
Figure 24: Global life sciences tools & services Market Segmentation II: % share, by value, 2009 43
Figure 25: Global life sciences tools & services market share: % share, by value, 2009 44
Figure 26: Forces driving competition in the global life sciences tools & services market, 2009 45
Figure 27: Drivers of buyer power in the global life sciences tools & services market, 2009 47
Figure 28: Drivers of supplier power in the global life sciences tools & services market, 2009 48
Figure 29: Factors influencing the likelihood of new entrants in the global life sciences tools & services market, 2009 49
Figure 30: Factors influencing the threat of substitutes in the global life sciences tools & services market, 2009 51
Figure 31: Drivers of degree of rivalry in the global life sciences tools & services market, 2009 52
Figure 32: Global life sciences tools & services market value forecast: $ billion, 2009–14 54
Figure 33: Global OTC pharmaceuticals market value: $ million, 2005–09 57
Figure 34: Global OTC pharmaceuticals market segmentation I:% share, by value, 2009 58
Figure 35: Global OTC pharmaceuticals Market Segmentation II: % share, by value, 2009 59
Figure 36: Global OTC pharmaceuticals market share: % share, by value, 2009 60
Figure 37: Forces driving competition in the global OTC pharmaceuticals market, 2009 61
Figure 38: Drivers of buyer power in the global OTC pharmaceuticals market, 2009 63
Figure 39: Drivers of supplier power in the global OTC pharmaceuticals market, 2009 64
Figure 40: Factors influencing the likelihood of new entrants in the global OTC pharmaceuticals market, 2009 65
Figure 41: Factors influencing the threat of substitutes in the global OTC pharmaceuticals market, 2009 67
Figure 42: Drivers of degree of rivalry in the global OTC pharmaceuticals market, 2009 68
Figure 43: Global OTC pharmaceuticals market distribution: % share, by value, 2009 69
Figure 44: Global OTC pharmaceuticals market value forecast: $ million, 2009–14 71
Figure 45: Global pharmaceuticals market value: $ billion, 2006–10(e) 74
Figure 46: Global pharmaceuticals market segmentation I:% share, by value, 2010(e) 75
Figure 47: Global pharmaceuticals Market Segmentation II: % share, by value, 2010(e) 76
Figure 48: Global pharmaceuticals market share: % share, by value, 2010(e) 77
Figure 49: Forces driving competition in the global pharmaceuticals market, 2010 78
Figure 50: Drivers of buyer power in the global pharmaceuticals market, 2010 79
Figure 51: Drivers of supplier power in the global pharmaceuticals market, 2010 81
Figure 52: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2010 83
Figure 53: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2010 85
Figure 54: Drivers of degree of rivalry in the global pharmaceuticals market, 2010 87
Figure 55: Global pharmaceuticals market value forecast: $ billion, 2010–15 89
Figure 56: Global pharmaceuticals, biotechnology & life sciences industry value: $ billion, 2005–09 93
Figure 57: Global pharmaceuticals, biotechnology & life sciences industry segmentation I:% share, by value, 2009 94
Figure 58: Global pharmaceuticals, biotechnology & life sciences industry segmentation II: % share, by value, 2009 95
Figure 59: Global pharmaceuticals, biotechnology & life sciences industry share: % share, by value, 2009 97
Figure 60: Forces driving competition in the global pharmaceuticals, biotechnology & life sciences industry, 2009 98
Figure 61: Drivers of buyer power in the global pharmaceuticals, biotechnology & life sciences industry, 2009 100
Figure 62: Drivers of supplier power in the global pharmaceuticals, biotechnology & life sciences industry, 2009 102
Figure 63: Factors influencing the likelihood of new entrants in the global pharmaceuticals, biotechnology & life sciences industry, 2009 103
Figure 64: Factors influencing the threat of substitutes in the global pharmaceuticals, biotechnology & life sciences industry, 2009 105
Figure 65: Drivers of degree of rivalry in the global pharmaceuticals, biotechnology & life sciences industry, 2009 107
Figure 66: Global pharmaceuticals, biotechnology & life sciences industry value forecast: $ billion, 2009–14 109
To order this report:
: Global: Pharmaceuticals Industry Guide
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article